Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.76 USD | +2.08% | -12.80% | -38.80% |
Jun. 03 | Oppenheimer Adjusts Immunovant Price Target to $46 From $50, Maintains Outperform Rating | MT |
May. 30 | Sector Update: Health Care Stocks Mixed Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.80% | 3.68B | |
+53.46% | 55.7B | |
+41.08% | 39.91B | |
-5.31% | 39.57B | |
-5.56% | 28.16B | |
+16.49% | 26.3B | |
-20.59% | 18.94B | |
+33.21% | 12.17B | |
+26.46% | 12.12B | |
+2.67% | 12.12B |
- Stock Market
- Equities
- IMVT Stock
- News Immunovant, Inc.
- Immunovant Insider Sold Shares Worth $383,012, According to a Recent SEC Filing